• About CCSB
  • |
  • News
  • |
  • Contact Us
  • |
  • Site Map
  •  
  •   中文版
CCSB's
  • ESG
  • Investor Relations
  • Events
  • Contract Research
  • Contract Manufacturing
  • API Products
CCSB API Products

API Products

Announcements
Financial
Annual Reports
Shareholders Services

Announcements

Home > Investor Relations >Announcements
2022/05/10 Announce the company's 2022Q1 consolidated financial reports approved by the board of directors
2022/04/20 Update private placement area-within two days from the date of the resolution of board of directors (private placement conversion of corporate bonds )
2022/04/20 Amendment of the issuance conditions for private placement of domestic convertible corporate bonds including secured or unsecured convertible corporate bonds
2022/04/12 CCSB is invited to attend 11th Taiwan CEO Week co-hosted by TWSE & QIC
2022/03/23 CCSB is invited to attend the Investor Conference held by Fubon Securities
2022/03/08 Resolution of the Board of Directors for convening the 2022 Annual General Shareholders' Meeting. (Adding Matters for Discussion)
2022/03/08 The Board of Directors Resolved to Distribute Dividend
2022/03/08 The Board of Directors approved the consolidated financial reports of 2021
2022/03/08 The board of directors of CCSB has resolved to handle private placement of domestic convertible corporate bonds (including secured or unsecured )
2022/03/08 The board of directors of the company has resolved to conduct private placement of ordinary shares
 Prev 1  2  3  4  5  6  7  8  9  10 Next  
© Chunghwa Chemical Synthesis & Biotech Co. Ltd. All right reserved.